Fish oil pills could help fight prostate cancer, new study hints

NCT ID NCT02333435

Ongoing Disease control Sponsor: CHU de Quebec-Universite Laval Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 2 trial tests whether taking omega-3 (EPA) supplements can reduce inflammation and slow cancer cell growth in men with high-risk prostate cancer who choose surgery. 130 participants will take either EPA capsules or a placebo for 14 months, starting before surgery. Researchers will measure changes in tumor growth markers and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Omega-3 (EPA) dietary supplement
What this could lead to: If it works, this could point toward a simple dietary supplement to help control prostate cancer growth and improve quality of life after surgery.
What could go wrong: This is an early phase 2 trial with only 130 participants. The supplement may not show a clear benefit, and results may not apply to all prostate cancer patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH RISK PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperplasia Inflammation prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Centre de Recherche Clinique et Evaluative en Oncologie - Hotel Dieu de Quebec

Québec, Quebec, G1R 3S1, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.